[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586934":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":30,"locations":35,"responsibleParty":207,"collaborators":24,"id":209,"slug":210,"hasResults":211,"nctId":212,"briefTitle":213,"officialTitle":214,"acronym":24,"eligibilityCriteria":215,"healthyVolunteers":211,"sex":216,"minAge":217,"maxAge":24,"enrollmentInfo":218,"targetDuration":24,"studyType":221,"phases":222,"briefSummary":225,"conditions":226,"keywords":229,"overallStatus":38,"whyStopped":24,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":233,"startDateStruct":236,"completionDateStruct":238,"leadSponsor":240,"locationsCount":241},{"fullName":5,"class":6},"Bolt Biotherapeutics, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose Escalation","EXPERIMENTAL","Escalating doses followed by backfill of selected doses",[13],"Drug: BDC-4182",{"label":15,"type":10,"description":16,"interventionNames":17},"Dose Expansion","Expansion at determined RP2D",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","BDC-4182","Immune stimulating antibody conjugate (ISAC), consisting of an anti-claudin 18.2 monoclonal antibody conjugated to a TLR 7\u002F8 dual agonist",[9,15],null,[26],{"name":27,"affiliation":28,"role":29},"Bolt Clinical Development","Bolt Biotherapeutics","STUDY_DIRECTOR",[31],{"name":28,"role":32,"phone":33,"phoneExt":24,"email":34},"CONTACT","+1 650 434 8640","clinicaltrials@boltbio.com",[36,52,63,75,87,98,110,121,129,137,145,158,166,177,188,196],{"facility":37,"status":38,"city":39,"state":40,"zip":24,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"AUS Site 2","RECRUITING","Darlinghurst","New South Wales","Australia","AU",{"type":44,"coordinates":45},"Point",[46,47],151.21925,-33.87939,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 8002",{"facility":53,"status":38,"city":54,"state":40,"zip":24,"country":41,"countryCode":42,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"AUS Site 5","Westmead",{"type":44,"coordinates":56},[57,58],150.98768,-33.80383,{"lat":58,"lon":57},[61],{"name":62,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 8005",{"facility":64,"status":38,"city":65,"state":66,"zip":24,"country":41,"countryCode":42,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"AUS Site 1","Birtinya","Queensland",{"type":44,"coordinates":68},[69,70],153.11913,-26.74322,{"lat":70,"lon":69},[73],{"name":74,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 8001",{"facility":76,"status":38,"city":77,"state":78,"zip":24,"country":41,"countryCode":42,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"AUS Site 4","Clayton","Victoria",{"type":44,"coordinates":80},[81,82],145.11667,-37.91667,{"lat":82,"lon":81},[85],{"name":86,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 8004",{"facility":88,"status":38,"city":89,"state":78,"zip":24,"country":41,"countryCode":42,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"AUS Site 3","Heidelberg",{"type":44,"coordinates":91},[92,93],145.06667,-37.75,{"lat":93,"lon":92},[96],{"name":97,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 8003",{"facility":99,"status":38,"city":100,"state":24,"zip":24,"country":101,"countryCode":24,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"SK Site 2003","Seongnam-si","South Korea",{"type":44,"coordinates":103},[104,105],127.13778,37.43861,{"lat":105,"lon":104},[108],{"name":109,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 2003",{"facility":111,"status":38,"city":112,"state":24,"zip":24,"country":101,"countryCode":24,"cosmosGeoPoint":113,"geoPoint":117,"contacts":118},"SK Site 2001","Seoul",{"type":44,"coordinates":114},[115,116],126.9784,37.566,{"lat":116,"lon":115},[119],{"name":120,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 2001",{"facility":122,"status":38,"city":112,"state":24,"zip":24,"country":101,"countryCode":24,"cosmosGeoPoint":123,"geoPoint":125,"contacts":126},"SK Site 2002",{"type":44,"coordinates":124},[115,116],{"lat":116,"lon":115},[127],{"name":128,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 2002",{"facility":130,"status":38,"city":112,"state":24,"zip":24,"country":101,"countryCode":24,"cosmosGeoPoint":131,"geoPoint":133,"contacts":134},"SK Site 2004",{"type":44,"coordinates":132},[115,116],{"lat":116,"lon":115},[135],{"name":136,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 2004",{"facility":138,"status":38,"city":112,"state":24,"zip":24,"country":101,"countryCode":24,"cosmosGeoPoint":139,"geoPoint":141,"contacts":142},"SK Site 2005",{"type":44,"coordinates":140},[115,116],{"lat":116,"lon":115},[143],{"name":144,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 2005",{"facility":146,"status":38,"city":147,"state":24,"zip":24,"country":148,"countryCode":149,"cosmosGeoPoint":150,"geoPoint":154,"contacts":155},"TWN Site 9004","Kaohsiung City","Taiwan","TW",{"type":44,"coordinates":151},[152,153],120.31333,22.61626,{"lat":153,"lon":152},[156],{"name":157,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 9004",{"facility":159,"status":38,"city":147,"state":24,"zip":24,"country":148,"countryCode":149,"cosmosGeoPoint":160,"geoPoint":162,"contacts":163},"TWN Site 9005",{"type":44,"coordinates":161},[152,153],{"lat":153,"lon":152},[164],{"name":165,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 9005",{"facility":167,"status":38,"city":168,"state":24,"zip":24,"country":148,"countryCode":149,"cosmosGeoPoint":169,"geoPoint":173,"contacts":174},"TWN Site 9001","Taichung",{"type":44,"coordinates":170},[171,172],120.6839,24.1469,{"lat":172,"lon":171},[175],{"name":176,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 9001",{"facility":178,"status":38,"city":179,"state":24,"zip":24,"country":148,"countryCode":149,"cosmosGeoPoint":180,"geoPoint":184,"contacts":185},"TWN Site 9003","Taipei",{"type":44,"coordinates":181},[182,183],121.52639,25.05306,{"lat":183,"lon":182},[186],{"name":187,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 9003",{"facility":189,"status":38,"city":179,"state":24,"zip":24,"country":148,"countryCode":149,"cosmosGeoPoint":190,"geoPoint":192,"contacts":193},"TWN Site 9006",{"type":44,"coordinates":191},[182,183],{"lat":183,"lon":182},[194],{"name":195,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 9006",{"facility":197,"status":38,"city":198,"state":24,"zip":24,"country":148,"countryCode":149,"cosmosGeoPoint":199,"geoPoint":203,"contacts":204},"TWN Site 9002","Taoyuan",{"type":44,"coordinates":200},[201,202],121.29696,24.99368,{"lat":202,"lon":201},[205],{"name":206,"role":32,"phone":24,"phoneExt":24,"email":24},"Site 9002",{"type":208,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100586934","phase-1-a-first-in-human-study-using-bdc-4182-as-a-single-agent-in-advanced-gastric-and-gastroesophageal-cancer-100586934",false,"NCT06921837","A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer","A Phase 1\u002F2, First-in-Human, Dose Escalation and Expansion Study of BDC-4182 as a Single Agent in Patients With Advanced Gastric and Gastroesophageal Cancer","Key Inclusion Criteria:\n\n* Has disease that is measurable by Response Evaluation Criteria in Solid Tumors (RECIST) v.1.1.\n* Subjects must have histologically\u002Fcytologically confirmed gastric or gastroesophageal cancer that is metastatic (Stage 4) or unresectable (Stage 3).\n* Subjects must have received at least 1-2 prior lines of locally available standard therapies or must be intolerant of standard therapies.\n* For subjects in escalation: If prior Claudin 18 IHC expression is known, the subject must have some degree of Claudin 18 expression as defined as Positive or have expression ≥ 1% of tumor cells IHC ≥ 2+. Consult with Medical Monitor as needed.\n* Adequate organ function\n* Agree to have a biopsy prior to enrollment, at acceptable risk in the judgement of the Investigator. If a biopsy is not safely accessible or clinically feasible, an adequate archival tumor sample must be submitted.\n\nKey Exclusion Criteria:\n\n* Known central nervous system (CNS) metastases except for disease that is asymptomatic, clinically stable, and has not required steroids for at least 14 days before starting study treatment.\n* Cardiac disease, pulmonary disease, or hepatic disease\n* Active infection\n* History of inflammatory eye disease\n* Residual toxicity from a previous treatment\n* Any investigational agent or standard anti-cancer therapies within 28 days before starting study treatment or within 5 estimated elimination half-lives, whichever is shorter.","ALL","18 Years",{"count":219,"type":220},122,"ESTIMATED","INTERVENTIONAL",[223,224],"PHASE1","PHASE2","A first-in-human study using BDC-4182 as a single agent in gastric and gastroesophageal cancers",[227,228],"Gastric Cancer Adenocarcinoma Metastatic","Gastroesophageal Adenocarcinoma",[230,231],"Gastric Cancer","Gastroesophageal Cancer","2026-01-23",{"date":234,"type":235},"2026-01-27","ACTUAL",{"date":237,"type":235},"2025-05-26",{"date":239,"type":220},"2029-05",{"name":5,"class":6},16]